Open Access
Subscription Access
Open Access
Subscription Access
The Results of the Clinical and Economic Assessment of Drugs Prescriptions to patients with Breast Cancer in the Ukrainian Health Care Institution
Subscribe/Renew Journal
The economic damage caused by breast cancer includes not only indirect costs, but also direct losses for the provision of medical care. Given that in Ukraine the main payer of expenses is the patient, the issue of cost effectiveness is relevant. The purpose of this work - to estimate efficiency of expenses for pharmacotherapy of patients with breast cancer according to the results of clinical and economic (combined ABC/VEN/frequency) analysis. For VEN analysis current regulatory medical and process documents that determine the provision of medical care to patients with BC, namely the Unified Clinical Protocol of Medical Aid to Patients with BC (Order of the Ministry of Health of Ukraine No. 396 dated 30.06.2015) and the State Formulary of Medicinal Products (2015) were used. The pooled АВС/VEN/frequency analysis was performed. 91 % of drugs in the prescriptions of doctors for the treatment of patients with BC were vital ones. 100% of the financial costs in the costliest group А fall on vital drugs (V category). It was found the high level of compliance of drug prescriptions with current regulatory medical and process documents and high efficiency of the costs of pharmacotherapy for patients with BC in Ukraine. The primary task of the health care system of Ukraine is to implement targeted programs aimed at preventing the impact of risk factors and increasing the economic affordability of sensitive diagnostic tests and modern therapies. This will allow both to reduce the incidence of BC, and diagnose an early stage, the treatment of which is more effective and requires less costs.
Keywords
Breast Cancer, Drug Prescriptions, Clinical And Economic Analysis, Frequency Analysis, VEN Analysis, АВС Analysis.
Subscription
Login to verify subscription
User
Font Size
Information
- Breast Cancer: Prevention and Control. WHO; 2015. Available from: URL: https://www.who.int/cancer/detection/breastcancer/en/
- Anders CK, Johnson R, Litton J, Phillips M and Bleyer A. Breast cancer before age 40 years. Semin Oncol. 36 (3); 2009:237-249. Available from: URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894028/
- Lakdawalla DN, Sun EC, Jena AB, Reyes CM, Goldmanc DP. and Philipsone TJ. An economic evaluation of the war on cancer. Journal of Health Economics. 29 (3); 2010: 333-346. Available from: URL: https://www.sciencedirect.com/science/article/abs/pii/S016762961 0000214
- Seabury SA, Goldman DP, Maclean JR, Penrod JR. and Lakdawalla DN. Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood). 31(4); 2012: 691-699.
- The global burden of disease: 2014 update. World Cancer Report 2014 / Edited by Bernard W. Stewart, Christopher P. Wild. Available from: URL: https://publichealth.wustl.edu/redefining- the-standard-of-care-in-cancer-treatment/
- Cancer in Ukraine, 2016-2017. Bulletin of the National Cancer Research Institute № 19. Available from: URL: http://www.ncru.inf.ua/publications/BULL_19/index.htm
- Cherenkov VG. Clinical Oncology: manual for the system of postgraduate education of doctors, Kiev, 2010.
- Fedorenko ZP, Gulak LO, Michailovich YuI, Ryzhov AYu, Sumkina OV. and Kutsenko LB. Evaluation of cancer to the population with the use of date of National cancer registry of Ukraine. Clinical Oncology. 3; 2015:7-12. Available from: URL: http://nbuv.gov.ua/UJRN/klinonk_2015_3_3
- Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H et al. A Systematic Analysis for the Global Burden of Disease Study. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015. JAMA Oncol. 3(4); 2017: 524-548.
- Order of the Ministry of Health of Ukraine No. 183 dated March 30, 2015 "On approval of the seventh issue of the State Form of Medicines and ensuring its availability". Available from: URL: http://www.moz.gov.ua/ua/portal/dn_20150330_0183.html
- Order of the Ministry of Health of Ukraine No. 396 dated June 30, 2015 "Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical aid. Breast cancer». Available from: URL: http://mtd.dec.gov.ua/images/dodatki/2015_396_RMZ/2015_396_ YKPMD_RMZ.pdf
- Iakovlieva LV, Bezditko NV, Gerasymova OA, Mishchenko OYa, Karbusheva IV, Tkachоva ОV and Berkalo NM. Pharmacoeconomics: a textbook for university students, Vinnytsia. 2017.
- Morozov AM, Iakovlieva LV, Bezditko NV, Mishchenko OYa, Matyashova NO, Adonkina VYu. Evaluation of the clinical and economic feasibility of the use of medicinal products in the medical-preventive institution (support of the formular system). Kiev. 2013.
- Reshetnikova AV, Shamshurin NG, Alekseeva VM. Application of clinical and economic analysis in medicine (definition of socio- economic efficiency). Kiev. 2009.
- Tkachova O, Silaev A, Ulanova V. and Butko Ya. Retrospective analysis of pharmacotherapy quality for children with acute respiratory infections on the background of ABC/VEN/frequency analysis based on disease cases data. J. Global Pharma Technology. 10 (07); 2018: 374-381. Available from: URL: http://www.jgpt.co.in/index.php/jgpt/article/view/1247/900
Abstract Views: 336
PDF Views: 0